CompanyMISTNasdaqMontreal, A8

Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals develops cardiovascular medicines.

SEC EDGAR ClinicalTrials.gov cardamyst.com

424B3Sep 10Latest SEC filing

Sep 3Latest story

September 2026

China's NMPA approves Milestone's etripamil nasal spray for PSVT

Sep 3Regulatory decisionetripamil Milestone Pharmaceuticals Inc.

August 2026

Milestone activates sites for Phase 3 AFib-RVR trial, reports $170.6M cash

Aug 12Quarterly updateetripamil Milestone Pharmaceuticals Inc.